APA (7th ed.) Citation

Jeong, C., Na, Y. J., Kim, T. Y., Lee, S. Y., Kim, J., & Ryou, S. (2025). In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-16949-8

Chicago Style (17th ed.) Citation

Jeong, Chae-Hong, Yoo Jin Na, Tae Yong Kim, So Young Lee, Jungyeon Kim, and Sangmi Ryou. "In Silico Screening and Experimental Validation Identify Riboflavin as an RNA-targeted Antiviral Against SARS-CoV-2." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-16949-8.

MLA (9th ed.) Citation

Jeong, Chae-Hong, et al. "In Silico Screening and Experimental Validation Identify Riboflavin as an RNA-targeted Antiviral Against SARS-CoV-2." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-16949-8.